Sofregen is a manufacturer of a biomedical silk protein intended to facilitate soft-tissue bulking and regeneration for a range of procedures in medical aesthetics and other medical applications. Sofregen’s Silk Voice®, a silk protein injectable implant & catheter, was cleared by the U.S. FDA in 2019 for vocal fold medialization and vocal fold insufficiency.
Company Details
- Employees
- 8
- Founded
- -
- Address
- 175 Crossing Boulevard,
- Industry
- Medical Equipment Manufacturing
- NAICS
-
Medical Equipment and Supplies ManufacturingSurgical and Medical Instrument ManufacturingSurgical Appliance and Supplies ManufacturingDental Equipment and Supplies ManufacturingOphthalmic Goods ManufacturingDental Laboratories
- Website
- sofregenmedical.com
- HQ
- Framingham, Massachusetts
Sofregen Inc. Questions
Sofregen Inc.'s website is sofregenmedical.com
Sofregen Inc.'s LinkedIn profile is https://www.linkedin.com/company/sofregen-medical
Sofregen Inc. has
8 employees.
View email and phone details for 8
employees at Sofregen Inc..
Sofregen Inc.'s industry is
Medical Equipment Manufacturing
Sofregen Inc.'s top competitors are
Nirrin,
Statadx,
Advanced Regenerative Manufacturing Institute (Armi) | Biofabusa,
Evoendo,
Airna,
Sarepta Therapeutics,
Genabio Diagnostics,
Anzu Partners,
Vaxess Technologies,
Jana Care.
Sofregen Inc.'s categories are Medical Equipment Manufacturing
Sofregen Inc.'s founding year is 2014
